- Home
- ICHR vs EVMN Comparison
ICHR vs EVMN Comparison
Compare ICHR & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICHR | EVMN |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 605.5M | 628.9M |
| IPO Year | 2016 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ICHR | EVMN |
|---|---|---|
| Price | $19.03 | $17.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $26.50 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 548.2K | 189.2K |
| Earning Date | 02-03-2026 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $957,337,000.00 | $13,000,000.00 |
| Revenue This Year | $13.48 | $89.43 |
| Revenue Next Year | $5.55 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 16.86 | ★ 160.00 |
| 52 Week Low | $13.12 | $13.89 |
| 52 Week High | $35.56 | $24.03 |
Technical Indicators
Market Signals| Indicator | ICHR | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | N/A |
| Support Level | $16.61 | N/A |
| Resistance Level | $18.99 | N/A |
| Average True Range (ATR) | 0.77 | 0.00 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 92.38 | 0.00 |
Price Performance
Historical ComparisonAbout ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.